echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > New research reveals the mechanism of "suicide" in combination with Bacillus

    New research reveals the mechanism of "suicide" in combination with Bacillus

    • Last Update: 2021-02-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    , according to a recent study, TB bacteria are killed by the toxins they produce unless the toxins are mesothlised by the detoxifying protein. The findings were published recently in the journal Molecular Cell. The team is now seeking to use this "suicide" mechanism for therapeutic purposes.
    bacteria to synthesize molecules that are toxic to themselves. When exposed to harsh environments, these toxins slow the growth of bacterial populations until more favourable conditions are formed. Some toxins even kill the bacteria that produce them. The biological purpose of this "suicide" remains a subject of debate. It may act as an antiviral defense mechanism, killing infected bacteria to avoid unoptid neighbors. Or, when faced with nutritional scarcity, you may "sacrifice" some for the benefit of many people. Under normal conditions, bacteria produce detoxifying proteins that mesify toxins.
    researchers found a "suicide toxin" called MvcT in mycobacterium tuberculosis bacteria. If it is not blocked by its antitoxin protein MbcA, MbcT toxin kills Mycobacteria tuberculosis by destroying its NAD storage.
    led by Olivier Neyrolles, a CNRS researcher at IBBS, has demonstrated the therapeutic potential of the toxin. They infect people and mouse cells with mycobacteria tuberculosis strains that lack this toxin/antitoxin system - but they can artificially trigger the production of MvcT toxins. Toxin activation significantly reduces the number of bacteria infected with cells and improves survival in mice.
    these findings pave the way for new treatments for tuberculosis, which remains one of the top 10 causes of death worldwide. Antibiotic resistance from certain mycobacteria tuberculosis strains only underlines this urgency. EMBL researchers have identified the three-dimensional structure of the MbcT-MbcA complex, and now different teams are working to find compounds that can release toxins from the antidotes associated with it. These molecules can also help fight other infectious diseases, as similar toxins/antitoxin systems have been detected in other pathogenic bacteria. (Bio Valley)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.